↓ Skip to main content

Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a prospective randomized study

Overview of attention for article published in European Journal of Clinical Pharmacology, May 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

news
1 news outlet
facebook
1 Facebook page

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
45 Mendeley
Title
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a prospective randomized study
Published in
European Journal of Clinical Pharmacology, May 2013
DOI 10.1007/s00228-013-1524-6
Pubmed ID
Authors

Hassan Seddik, Samir Ahid, Tarek El Adioui, Fatim-Zohra El Hamdi, Mohammed Hassar, Redouane Abouqal, Yahia Cherrah, Ahmed Benkirane

Abstract

Eradication rates following standard triple therapy for Helicobacter pylori infection are declining. Recent studies, conducted in a number of countries, have shown that sequential therapy for H. pylori infection yields high cure rates.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 45 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 22%
Student > Master 6 13%
Other 4 9%
Student > Ph. D. Student 4 9%
Researcher 3 7%
Other 7 16%
Unknown 11 24%
Readers by discipline Count As %
Medicine and Dentistry 20 44%
Agricultural and Biological Sciences 5 11%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Biochemistry, Genetics and Molecular Biology 2 4%
Immunology and Microbiology 2 4%
Other 2 4%
Unknown 12 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 November 2018.
All research outputs
#4,087,640
of 22,714,025 outputs
Outputs from European Journal of Clinical Pharmacology
#368
of 2,552 outputs
Outputs of similar age
#35,326
of 195,609 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#8
of 25 outputs
Altmetric has tracked 22,714,025 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,552 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 195,609 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.